Impact of Cusp-Overlap Technique on Pacemaker Requirement after Transcatheter Aortic Valve Implantation

pp 136-139

Authors

  • Matías Sztejfman Department of Interventional Cardiology, Sanatorio Güemes, Buenos Aires, Argentina.- Department of Interventional Cardiology, Sanatorio Finochietto, Buenos Aires, Argentina.
  • Carlos Maximiliando Giuliani Department of Interventional Cardiology, Sanatorio Güemes, Buenos Aires, Argentina.-Department of Interventional Cardiology, Sanatorio Finochietto, Buenos Aires, Argentina.
  • Sebastián Peralta Department of Interventional Cardiology, Sanatorio Güemes, Buenos Aires, Argentina.
  • Ezequiel José Zaidel Department of Interventional Cardiology, Sanatorio Güemes, Buenos Aires, Argentina. https://orcid.org/0000-0001-8349-7507
  • Luis Carlos Sztejfman Department of Interventional Cardiology, Sanatorio Güemes, Buenos Aires, Argentina.- Department of Interventional Cardiology, Sanatorio Finochietto, Buenos Aires, Argentina.
  • Marcelo Omar Bettinotti Department of Interventional Cardiology, Sanatorio Güemes, Buenos Aires, Argentina.

DOI:

https://doi.org/10.7775/rac.es.v89.i2.19091

Keywords:

Transcatheter aortic valve replacement, Atrioventricular block, Pacemaker, Artificial, Heart Valve Prosthesis Implantation, methods

Abstract

Background: Persistent bradyarrhythmias requiring permanent pacemaker implantation are a common complication after transcatheter aortic valve implantation (TAVI), but high implantation with cusp-overlap technique could prevent conduction system disturbances.

Objective: The aim of this study was to assess the rate of pacemaker use in patients who received TAVI with conventional coplanar technique compared with cusp overlap technique.

Methods: A total of 65 consecutive patients from two centers receiving Evolut-R or Evolut-Pro valve implantation, 50 coplanar and 15 cusp-overlap, were analyzed between 2017 and 2019.

Results: Mean age was 80 years, and there were no differences in risk according to the EuroSCORE. The rate of pacemaker requirement was 0% in cusp-overlap procedures compared with 24.9% in those with conventional implantation (OR=0.0; 95% CI 0-0.89; p=0.041). In addition, cusp-overlap implants presented lower rate of major complications (6.67% vs. 42%; OR=0.09; 95% CI 0.01-0.8; p=0.011).

Conclusions: In this cohort, TAVI procedure with cusp-overlap technique was associated with null pacemaker requirement. Given the potential large-scale impact, external validation of results is needed.

Published

2025-04-25

Issue

Section

BRIEF ARTICLES

Most read articles by the same author(s)

1 2 > >>